Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Average Recommendation of “Moderate Buy” from Brokerages
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has received an average rating of “Moderate Buy” from the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, six have given a buy recommendation and one has […]
14 Sep 06:15 · The Cerbat Gem